JPH0479349B2 - - Google Patents
Info
- Publication number
- JPH0479349B2 JPH0479349B2 JP4560184A JP4560184A JPH0479349B2 JP H0479349 B2 JPH0479349 B2 JP H0479349B2 JP 4560184 A JP4560184 A JP 4560184A JP 4560184 A JP4560184 A JP 4560184A JP H0479349 B2 JPH0479349 B2 JP H0479349B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- compound
- general formula
- aryl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 37
- 125000000217 alkyl group Chemical group 0.000 claims description 17
- 150000008065 acid anhydrides Chemical class 0.000 claims description 13
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 125000003107 substituted aryl group Chemical group 0.000 claims description 13
- BXUURYQQDJGIGA-UHFFFAOYSA-N N1C=NN2N=CC=C21 Chemical class N1C=NN2N=CC=C21 BXUURYQQDJGIGA-UHFFFAOYSA-N 0.000 claims description 12
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 11
- MPSUGQWRVNRJEE-UHFFFAOYSA-O 1h-triazol-1-ium-1-amine Chemical class NN1C=C[NH+]=N1 MPSUGQWRVNRJEE-UHFFFAOYSA-O 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 150000003852 triazoles Chemical class 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 238000007363 ring formation reaction Methods 0.000 claims description 5
- 238000009833 condensation Methods 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 75
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- 238000003786 synthesis reaction Methods 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000010992 reflux Methods 0.000 description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 13
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- -1 polycyclic compound Chemical class 0.000 description 9
- 239000000741 silica gel Substances 0.000 description 9
- 229910002027 silica gel Inorganic materials 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- LWVQKUOEBYLTIJ-UHFFFAOYSA-N 1-(1-benzyl-2,6-dimethylpyrazolo[1,5-b][1,2,4]triazol-7-yl)ethanone Chemical compound C12=C(C(=O)C)C(C)=NN2N=C(C)N1CC1=CC=CC=C1 LWVQKUOEBYLTIJ-UHFFFAOYSA-N 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 7
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical group C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- HTPVZSAADONHSO-UHFFFAOYSA-N 1-benzyl-2,6-dimethylpyrazolo[1,5-b][1,2,4]triazole Chemical compound CC1=NN2N=C(C)C=C2N1CC1=CC=CC=C1 HTPVZSAADONHSO-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- BUZPVQSKAPILPH-UHFFFAOYSA-N [I-].N[NH+]1N=NC=C1 Chemical compound [I-].N[NH+]1N=NC=C1 BUZPVQSKAPILPH-UHFFFAOYSA-N 0.000 description 3
- YEDVUDDWJVRKIS-UHFFFAOYSA-N cyclopenta[b]pyrrole Chemical compound C1=C[C]2[N]C=CC2=C1 YEDVUDDWJVRKIS-UHFFFAOYSA-N 0.000 description 3
- NWADXBLMWHFGGU-UHFFFAOYSA-N dodecanoic anhydride Chemical compound CCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCC NWADXBLMWHFGGU-UHFFFAOYSA-N 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- UUOAGWVHHIWLBN-UHFFFAOYSA-N 3-o-(3-methoxy-2-methyl-3-oxopropanoyl) 1-o-methyl 2-methylpropanedioate Chemical compound COC(=O)C(C)C(=O)OC(=O)C(C)C(=O)OC UUOAGWVHHIWLBN-UHFFFAOYSA-N 0.000 description 2
- VYJYRRJJBRMGQI-UHFFFAOYSA-N 4-(4-nitrophenyl)butanoyl 4-(4-nitrophenyl)butanoate Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCCC(=O)OC(=O)CCCC1=CC=C([N+]([O-])=O)C=C1 VYJYRRJJBRMGQI-UHFFFAOYSA-N 0.000 description 2
- BDRBKTLTJIZWFI-UHFFFAOYSA-M 4-benzyl-3,5-dimethyltriazol-3-ium-1-amine;iodide Chemical compound [I-].C[N+]1=NN(N)C(C)=C1CC1=CC=CC=C1 BDRBKTLTJIZWFI-UHFFFAOYSA-M 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- DQPBABKTKYNPMH-UHFFFAOYSA-N amino hydrogen sulfate Chemical compound NOS(O)(=O)=O DQPBABKTKYNPMH-UHFFFAOYSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 238000005947 deacylation reaction Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229940071870 hydroiodic acid Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- YLACRFYIUQZNIV-UHFFFAOYSA-N o-(2,4-dinitrophenyl)hydroxylamine Chemical compound NOC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O YLACRFYIUQZNIV-UHFFFAOYSA-N 0.000 description 2
- SJECIYLGISUNRO-UHFFFAOYSA-N o-diphenylphosphorylhydroxylamine Chemical compound C=1C=CC=CC=1P(=O)(ON)C1=CC=CC=C1 SJECIYLGISUNRO-UHFFFAOYSA-N 0.000 description 2
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 description 1
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
- YVDWFZIVIIKYBQ-UHFFFAOYSA-N 2,5-dimethyl-1,3,4-oxadiazole Chemical compound CC1=NN=C(C)O1 YVDWFZIVIIKYBQ-UHFFFAOYSA-N 0.000 description 1
- MZWDAEVXPZRJTQ-WUXMJOGZSA-N 4-[(e)-(4-fluorophenyl)methylideneamino]-3-methyl-1h-1,2,4-triazole-5-thione Chemical compound CC1=NNC(=S)N1\N=C\C1=CC=C(F)C=C1 MZWDAEVXPZRJTQ-WUXMJOGZSA-N 0.000 description 1
- KDKOUILSLKTPNI-UHFFFAOYSA-N 4-benzyl-1,2,4-triazole Chemical compound C1=NN=CN1CC1=CC=CC=C1 KDKOUILSLKTPNI-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- NTGIYBRBEHXTQS-UHFFFAOYSA-N CCOC(=O)C(C)C(=O)OC(=O)C(C)C(=O)OCC Chemical compound CCOC(=O)C(C)C(=O)OC(=O)C(C)C(=O)OCC NTGIYBRBEHXTQS-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005036 alkoxyphenyl group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940051881 anilide analgesics and antipyretics Drugs 0.000 description 1
- 150000003931 anilides Chemical class 0.000 description 1
- 125000001743 benzylic group Chemical group 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000004802 cyanophenyl group Chemical group 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- BEQVQKJCLJBTKZ-UHFFFAOYSA-N diphenylphosphinic acid Chemical compound C=1C=CC=CC=1P(=O)(O)C1=CC=CC=C1 BEQVQKJCLJBTKZ-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- VGGRCVDNFAQIKO-UHFFFAOYSA-N formic anhydride Chemical compound O=COC=O VGGRCVDNFAQIKO-UHFFFAOYSA-N 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- UMHTVKGNHVUENZ-UHFFFAOYSA-N n,n',n'-triacetylacetohydrazide Chemical group CC(=O)N(C(C)=O)N(C(C)=O)C(C)=O UMHTVKGNHVUENZ-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 230000009935 nitrosation Effects 0.000 description 1
- 238000007034 nitrosation reaction Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
【発明の詳細な説明】
(発明の分野)
本発明は、新規なピラゾロ[1,5−b][1,
2,4]トリアゾール誘導体の製造方法に関す
る。
(発明の背景)
橋頭位に窒素原子を有し、この窒素原子とさら
にもう1つの窒素原子の孤立電子対を含めて10個
のπ電子の相互作用が可能な、全体で最低2個、
最高6個の窒素原子を有する一般式
…;移りうる3つの二重結合を示す。
・;窒素又は炭素原子を示す。
で表わされる5−5縮合多環系化合物は通例「ア
ザペンタレン」と呼ばれる。この化合物はこれま
で構造化学的な興味、整理活性物質としての興味
及び写真化学におけるマゼンタカプラーとしての
興味から主に研究がなされてきた(J.Elgureo,
R.Jacquier,S.Mignonac−Mondon,J.
Heterocyclic.Chem.,10,411(1973),H.Koga,
M.Hirobe,T.Okamoto,Chem.Pharm.Bull.,
22,482(1974),J.Bailey,J.C.S.Perkin I2047
(1977)、特公昭47−27411号、特開昭50−129586
号など参照)。
本発明者らはこのようなアザペンタレン化合物
の合成法について種々研究を重ねた結果、ある種
のN−アミノトリアゾリウム塩と酸無水物とを環
化縮合させることにより新規な骨格のアザペンタ
レン化合物を得ることができ、該化合物がカラー
写真のマゼンタカプラーとして極めて優れた特性
を示すことを見い出し、この知見に基づき本発明
をなすに至つた。
(発明の構成)
すなわち本発明は、
1 一般式
(式中、R1は水素原子、アルキル基、置換ア
ルキル基、アリール基又は置換アリール基を示
し、R2はアルキル基、置換アルキル基、アリー
ル基又は置換アリール基を示し、Xは酸根を示
す。)
で表わされるN−アミノトリアゾリウム塩と、一
般式
(R3CO)2O
又は
(式中、R3は水素原子、アルキル基、置換ア
ルキル基、アリール基又は置換アリール基を示
す。)
で表わされる酸無水物とを環化縮合させて一般式
(式中、R1,R2及びR3は前記と同じ意味をも
つ。)
で表わされる7−アシル化ピラゾロ[1,5−
b][1,2,4]トリアゾールを得、この化合
物の7位のアシル基を脱アシル化して一般式
(式中、R1,R2及びR3は前記と同じ意味をも
つ。)
で表わされるピラゾロ[1,5−b][1,2,
4]トリアゾール誘導体を得、この化合物の1位
を還元して、一般式
(式中、R1及びR3は前記と同じ意味をもつ。)
で表わされる化合物とすることを特徴とするピラ
ゾロ[1,5−b][1,2,4]トリアゾール
誘導体の製造方法、及び
2 一般式
(式中、R1は水素原子、アルキル基、置換ア
ルキル基、アリール基又は置換アリール基を示
し、R2はアルキル基、置換アルキル基、アリー
ル基又は置換アリール基を示す。)
で表わされるトリアゾール化合物をN−アミノ化
して前記一般式
(式中、R1及びR2は前記と同じ意味をもつ。
Xは酸根を示す。)
で表されるN−アミノトリアゾリウム塩を得、こ
のN−アミノトリアゾリウム塩を前記1)項の方
法と同様に一般式()で表わされる酸無水物と
を環化縮合させて、一般式()で表わされる7
−アシル化ピラゾロ[1,5−b][1,2,4]
トリアゾールを得、この7位のアシル基を脱アシ
ル化して前記一般式()で表わされるピラゾロ
[1,5−b][1,2,4]トリアゾール誘導体
を得、この1位を還元して、前記一般式()で
表わされる化合物を得ることを特徴とするピラゾ
ロ[1,5−b][1,2,4]トリアゾール誘
導体の製造方法。
を提供するものである。
上記一般式(),(),(),(),()
及
び()で表わされる化合物においてR1及びR3
のアルキル基はメチル、エチル、プロピル、ブチ
ル基のような低級アルキル基から炭素原子数22ま
での高級アルキル基、例えば、ペンチル基、ヘキ
シル基、ヘプチル基、オクチル基、デシル基、ウ
ンデシル基、トリデシル基、オクタデシル基など
を意味し、直鎖でも分岐鎖でもよい。特にR1と
してはメチル基が好ましい。またR1,R3のアリ
ール基としてはフエニル基、ナフチル基などがあ
げられ、置換アルキル基としては、ベンジル基、
フエネチル基などが、置換アリール基としてはハ
ロゲノフエニル基、ニトロフエニル基、シアノフ
エニル基、アルコキシフエニル基などがあげられ
る。またこれらのR1及びR3は反応に不活性な基、
例えばアルコキシル基、ニトロ基、シアノ基、ハ
ロゲン原子などを置換基として有していてもよ
い。
次に上記一般式()及び()で表わされる
化合物中R2のアルキル基としては、メチル基、
エチル基、プロピル基、ブチル基などの低級アル
キル基及びペンチル基、ヘキシル基、ドデシル基
などの高級アルキル基が含まれ、アリール基とし
てはフエニル基、ナフチル基などが、置換アルキ
ル基としてはベンジル基、フエネチル基、p−メ
トキシフエニルメチル基、m−ニトロフエニルメ
チル基などが含まれ、これらは、R1,R3と同様
の反応に不活性な基を置換基として有していても
よい。特にR2が置換されていてもよいベンジル
基の場合は、後の工程で該置換基を還元的に除去
しやすいために、1H−体を製造する場合は有利
である。
上記一般式()中、Xの酸根としては酸根、
例えば塩素、臭素、ヨウ素などのハロゲンアニオ
ン、NO3
,SO2- 4,【式】
【式】
【式】【式】
などが包含される。
なお、本発明方法により得られるピラゾロ
[1,5−b][1,2,4]トリアゾール誘導体
であつて、R1,R2又はR3の基上に上記のように
さらに置換機を有する化合物は、後記反応行程式
に従つて直接得ることができるが、この行程でま
ず本発明の基本骨格であるピラゾロ−[1,5−
b][1,2,4]トリアゾール環を形成してか
ら、後続反応によつて所望の置換基へと誘導して
もよい。必要な場合には7−位がアシル基、R2
がベンジル基などの保護基を有する化合物で誘導
してもよい。例えば後の実施例6において示すよ
うに本発明の化合物11〜のアミノ基は公知の方法
で酸アニリド13〜などに誘導できる。
本発明方法の反応行程は、前記一般式()の
Xがヨウ素イオンの場合について示せば次の通り
である。
なお、本発明方法により得られた一般式()
で表わされる化合物の7位に写真用カプラーにお
いて周知のカツプリング離脱基を導入して写真用
カプラーとしてもよい。これは下記の反応工程中
()→()の工程で示される。
反応行程式
以下、上記反応行程式に従い本発明方法の実施
態様を説明する。
本発明においてトリアゾール化合物()はオ
キサジアゾール()と有機一級アミン()と
の反応により容易に得られる。反応温度は通常50
〜150℃の範囲で開始させ、脱水反応の生成水が
おだやかに還流する条件で完結させる。反応時間
は通常0.1〜6時間の範囲であるがこれに限定さ
れない。なおオキサジアゾールはBer.,32巻797
頁(1899年)に記載の方法で合成することができ
る。
次にトリアゾール化合物()のアミノ化によ
るN−アミノトリアゾリウム塩()の合成は、
アミノ化剤としてヒドロキシルアミン−O−スル
ホン酸、O−(2,4−ジニトロフエニル)ヒド
ロキシルアミン、O−ジフエニルホスホリルヒド
ロキシルアミンを用いて行うことができる。本発
明に使用しうるその他のアミノ化剤は、Y.
Tamuraet,al,Synthesis,1977,1〜17及び同
文献の引例に記載されている。このアミン化反応
は、通常、反応温度0℃〜100℃で0.1〜5時間の
範囲で行う。トリアゾール化合物とアミノ化剤の
モル比は一般に1:1であるが、両者のうち安価
な方を過剰に使用してもよい。
N−アミノトリアゾリウム塩()と酸無水物
()との環化縮合反応は塩基の存在下で行われ
る。塩基としてはアミン類、酢酸ナトリウム、プ
ロピオン酸ナトリウムなどを用いることができ
る。この反応において、N−アミノトリアゾリウ
ム塩に対し、酸無水物を少なくとも3当量、塩基
を少なくとも5当量用いることが望ましい。酸無
水物及び塩基の量がこの下限未満では、反応収率
が低下する。これは、酸無水物が前記下限未満で
は、反応中間体から目的物を与えない副反応が進
行するためと考えられる。反応温度は一般に100
℃〜180℃が使用できるが120℃以上が好ましく、
反応時間は酸無水物の種類及び量により異なり、
特に制限はないが一般に0.5〜20時間の範囲であ
る。反応溶媒は不活性溶媒であればどのようなも
のでもよく、例えばジメチルホルムアミド
(DMF)、ジメチルアセトアミド、N−メチルピ
ロリドンなどが通常用いられるが、低級の酸無水
物を反応成分として用いるときは、これを過剰量
として溶媒とすることもできる。
酸無水物()の具体例としては、無水ギ酸、
無水酢酸、無水プロピオン酸、無水ラウリン酸、
無水安息香酸、無水メトキシカルボニルプロピオ
ン酸、無水エトキシカルボニルプロピオン酸、無
水4−(p−ニトロフエニル)酪酸などがあげら
れる。また上記一般式()の酸無水物には混合
酸無水物も包含されるが、この場合の具体例とし
ては、トリメチル酢酸との混合酸無水物が好まし
いものとしてあげられる。
この環化縮合反応の生成物である7−アシル化
ピラゾロ[1,5−b][1,2,4]トリアゾ
ール()を脱アシル化により、化合物()が
得られる。
脱アシル化は、一般的な方法に準じて、鉱酸に
よる酸性条件下、室温〜200℃で沸騰する溶剤例
えば、エタノールなどを含む水溶液中で加熱還流
することにより達成できる。これを中性に戻した
後、目的物を抽出などによる単離し、必要に応じ
精製する。
なお、脱アシル化反応は、7位のニトロソ化と
同時に行うようにしてもよい。
次に化合物()の還元により、1−位の窒素
原子に結合した置換基R2が除去されて1H−ピラ
ゾロ[1,5−b][1,2,4]トリアゾール
化合物()が得られる。置換基R2はこの還元
処理により好適に除去し得るものを選択すること
が望ましい。このような保護基については、例え
ばMcomie著 Protective Groups in Organic
Chemistry(1973年、Plenum社刊)あるいは、T.
W.Green著 Protective Groups in Organic
Synthesis(1981年、Wiley−Interscience社刊)
に多く記載されている。この中でも、本発明に使
用するのに好ましいR2としては、
−CH2C6H5,−CH(C6H5)2,
−CH2C6H3−3,4−(OCH3)2,
−CH2C6H4−o−NO2,
−CH2C6H4−p−OCH3,
−CH(C6H4−p−OCH3)2,
−CH2−2−ピリジル−N−オキシド
などがある。これらの置換基R2を除去するため
の反応条件としては、接触還元あるいはアルカリ
金属による還元などがある。この例をあげると、
パラジウム黒/水素、パラジウム−炭素/水素、
パラジウム−アルミナ/水素、ナトリウム/液体
アンモニア、リチウム/液体アンモニアなどがあ
る。なかでもナトリウム金属/液体アンモニウム
が高い収率を与える。
上記反応行程の各工程で、得られる所望化合物
は何ら単離することなく引き続く反応に供しても
よいが、通常適当な単離手段により単離精製され
る。このような手段としては例えば溶媒抽出法、
再結晶法、ろ過法、カラムクロマトグラフイー、
薄層クロマトグラフイー等を例示できる。
次に、上記一般式(),()及び()で表
わされるピラゾロ[1,5−b][1,2,4]
トリアゾール誘導体の具体例を以下に例示する
が、本発明はこれによつて限定されるものでない
ことは勿論である。
ただし、下記例示化合物中、4,14,16,17〜
20は、本発明の目的化合物である1H−ピラゾロ
[1,5−b][1,2,4]トリアゾール誘導体
の7位にさらに写真用カプラーのカツプリング離
脱基を導入して得られる化合物を示し、参考化合
物として示すものである。
(発明の効果)
本発明によれば、カラー写真のマゼンタカプラ
ーとして、また、写真用増感色素製造の中間体と
して有用な、新規なアザペンタレン化合物である
ピラゾロ[1,5−b][1,2,4]トリアゾ
ール誘導体を製造することができる。また本発明
の化合物は、生理活性物質として使用できる可能
性を有し、さらに医薬品製造の中間体となりう
る。
(実施例)
次に本発明を実施例に基づきさらに詳細に説明
する。
実施例1 (例示化合物1〜,2〜,3〜の合成)
(A) 1−アミノ−4−ベンジル−3,5−ジメチ
ルトリアゾリウムヨージド()の合成
なお以下の実施例中、()として、特に断わ
らない限り、この1−アミノ−4−ベンジル−
3,5−ジメチルトリアゾリウムヨージドを使用
した。
()テトラアセチルヒドラジンの熱分解によ
り得られる2,5−ジメチル−1,3,4−オキ
サジアゾール()19g(0.19mol)とベンジル
アミン31g(0.29mol)を110℃で4時間反応さ
せ、4−ベンジル−3,5−ジメチル−1,2,
4−トリアゾール()26gを得た。収率73%、
融点125〜127℃。
ヒドロキシルアミン−O−スルホン酸66g
(0.58mol)と水酸化カリウム40g(85%、
0.61mol)とから調製したヒドロキシルアミン−
O−スルホン酸カリウムの水溶液と上記トリアゾ
ール()75g(0.4mol)とを80〜90℃で6時
間反応させ、室温に戻したのち、50%の炭酸カリ
ウム水溶液でPH8〜9に調節した。生成した硫酸
カリウムをろ別し、ろ液をクロロホルムで3回抽
出した。このクロロホルム抽出液から出発物質で
あるトリアゾールが44g(59%)回収された。水
層を氷冷下57%ヨウ化水素酸水溶液でPH3にする
と結晶が析出した。この結晶をろ別し、−20℃で
エタノールから再結晶することにより()39g
(31%)を淡黄色結晶として得た。
()アミノ化剤としてO−(2,4−ジニ
トロフエニル)ヒドロキシルアミン(J.Org.
Chem.38 1239(1973))を使用して、次のように
して()を合成した。
4−ベンジル−1,2,4−トリアゾール
()35g(0.19mol)をジクロロエタン300mlに
加え、70℃に加熱下に激しく攪拌し、この中にO
−(2,4−ジニトロフエニル)ヒドロキシルア
ミン25g(0.13mol)を少しずつ(約35分間にわ
たり)加え、さらにこの温度で2時間攪拌した。
ジクロロエタンを減圧留去後、100mlの水に残渣
を溶かし、57%のヨウ化水素酸水溶液でPHを3に
した。2,4−ジニトロフエノールが析出してく
るが、酢酸エチルで抽出(3回)して除去した。
水層を濃縮し、残渣をエタノールから再結晶させ
て()を収率70%で得た。
なお、アミノ化剤として、O−ジフエニルホス
フイニルヒドロキシルアミン(Synthesis,592
(1982),Tetrahedron Lett.,23,3835(1982))
を使用する場合もほぼ同様に行うが、この場合、
ヨウ化水素酸で処理後、抽出することなくジフエ
ニルホスフイン酸をろ過により回収(90%以上)
することができた。
(B) 7−アセチル−1−ベンジル−2,6−ジメ
チルピラゾロ[1,5−b][1,2,4]ト
リアゾール(1)〜の合成
N−アミノトリアゾリウムヨージド()8g
(0.025mol)をDMF(ジメチルホルムアミド)50
mlに溶かし、無水酢酸40mlを加え、120℃に加熱
した。次いで酢酸ナトリウム12.5gを加え、120
〜130℃で4時間攪拌した。DMF、無水酢酸など
を減圧留去後、飽和の炭酸ナトリウム水溶液で塩
基性としたのちクロロホルムで抽出し、抽出液を
無水硫酸マグネシウムで乾燥後、溶媒を留去した
ところ褐色の油状物が得られた。これをn−ヘキ
サン−酢酸エチルの溶媒系でシリカゲルカラムに
より精製して、7−アセチル−1−ベンジル−
2,6−ジメチルピラゾロ[1,5−b][1,
2,4]トリアゾール(1)〜3.2g(47%)を得た。
融点105〜107℃
核磁気共鳴スペクトル(CDCl3)
δ(ppm):2.36(3H,s)2.43(3H,s)2.60
(3H,s)5.80(2H,s)7.0〜7.2(2H)7.2
〜7.36(3H)
(C) 1−ベンジル−2,6−ジメチルピラゾロ
[1,5−b][1,2,4]トリアゾール(2)〜の
合成
1〜,2g(7.5mmol)を20mlのエタノールに溶
かし、これに濃塩酸20mlを加え、加熱還流する。
約6時間後エタノールを減圧留去し、重炭酸ナト
リウムの飽和水溶液で塩基性にしたのち酢酸エチ
ルで抽出するとほぼ純粋な脱アセチル化1−ベン
ジル−2,6−ジメチルピラゾロ[1,5−b]
[1,2,4]トリアゾール(2)〜1.6g(95%)を得
た。融点87〜88℃
核磁気共鳴スペクトル(CDCl3)
δ(ppm):2.32(3H,s)2.44(3H,s)5.02
(2H,s)5.22(1H,s)7.10〜7.40(5H)
(D) 1H−2,6−ジメチルピラゾロ[1,5−
b][1,2,4]トリアゾール(3)〜の合成
1−ベンジル−2,6−ジメチルピラゾロ
[1,5−b][1,2,4]トリアゾール(2)〜1.6
g(7.1mmol)を液体アンモニア中約0.8gの金
属ナトリウムで還元し、目的とする1H−2,6
−ジメチルピラゾロ[1,5−b][1,2,4]
トリアゾール(3)〜0.67g(70%)を無色の結晶とし
て得た。融点274〜275℃(分解)
質量分析136(M+,100%)
元素分析値 C(%) H(%) N(%)
理論値 52.93 5.92 41.15
測定値 52.85 6.02 41.01
核磁気共鳴スペクトル(CDCl3:ピリジン−d5
=1:1)
δ(ppm):2.35(3H,s)2.43(3H,s)5.50
(1H,s)
〈実施例2〉 (例示化合物5〜の合成)
実施例1で示したN−アミノトリアゾリウムヨ
ージド()5g(16mmol)と5当量の無水ラ
ウリン酸30g(79mmol)及びトリプロピルアミ
ン11g(77mmol)をDMF100ml中140〜150℃で
約10時間加熱した。DMFをエバポレータで除き
酢酸エチルを加え、析出した未反応の無水ラウリ
ン酸をろ過により除きろ液を分液ロートに移し、
2Nの水酸化ナトリウム水溶液を加え十分振り、
分液した。水層をさらに2回酢酸エチルで抽出
し、酢酸エチル層を飽和の食塩水で洗つたのち、
硫酸マグネシウムで乾燥し、得られた残渣に濃塩
酸30mlとエタノール50mlを加え約4時間加熱還元
後、エタノールを除去し、酢酸エチルで抽出し
た。通常の後処理を行い、シリカゲルカラムで精
製し、1−ベンジル体を0.8g(14%)得た。
核磁気共鳴スペクトル(CDCl3)
δ(ppm):0.88(3H,brt,J=〜7)1.30
(20H,brs)2.40(3H,s)2.60(2H,t,
J=7.5)5.03(2H,s)5.25(1H,s)7.10
〜7.45(5H)
この1−ベンジル体を液体アンモニア中ナトリ
ウムで還元してアルコール以外の有機溶媒に難溶
な例示化合物5〜を約90%の収率で得た。融点154
〜155℃
〈実施例3〉 (例示化合物6の合成)
n−ヘプタン酸7.2g(55mmol)をジメチルホ
ルムアミド(DMF)15mlに溶かし、その中にト
リ−n−プロピルアミン7.9g(55mmol)を加
え、次にDMF10mlに溶かしたトリメチルアセチ
ルクロリド6.1g(51mmol)を滴下して加えた。
10分間室温で攪拌後、N−アミノトリアゾリウム
ヨージド()5g(15.8mmol)とトリ−nプ
ロピルアミン11.3g(79mmol)を加え徐々に150
℃に加熱し、その温度で約5時間攪拌した。
DMFとアミンを減圧留去後2N水酸化ナトリウム
水溶液100mlを加え、酢酸エチルにより3回抽出
し、抽出液を水と飽和食塩水で洗い硫酸マグネシ
ウム上で乾燥した。ろ過後減圧濃縮し、残渣をシ
リカゲルクロマトグラフイーにより精製し、()
(R1=−CH3,【式】R3=−
C6H13)
を2.9g(45%)得た。
これを実施例1の(C)(D)で示した方法により脱ア
シル化及び脱ベンジル化すると6〜を1.0g(68%)
得ることができた。融点105〜110℃
核磁気共鳴スペクトル(DMSO−d6)
δ(ppm):0.85(3H,brt,J=〜7)1.32
(8H,brs)2.45(3H,s)2.58(2H,t,J
=7.5)5.60(1H,s)
〈実施例4〉 (例示化合物7〜の合成)
()1.0g(3.16mmol)を無水DMFの8ml
に溶かし、その溶液中に無水安息香酸3.6g
(15.8mmol)とトリ−n−プロピルアミン2.3g
(15.8mmol)を加え、130℃で24時間加熱攪拌し
た。DMFとトリ−n−プロピルアミンを減圧留
去後エタノール30ml、濃塩酸10mlを加え5日間加
熱還流した。エタノールと濃塩酸を減圧留去後、
酢酸エチルで抽出し、乾燥、濃縮後、シリカゲル
クロマトグラフイーで精製すると1−ベンジル体
0.2g(22%)が得られた。
核磁気共鳴スペクトル(CDCl3)
δ(ppm):2.35(3H,s)4.95(2H,s)5.65
(1H,s)7.05〜7.50(8H)7.80(2H,dd,
J=9.0,1.5)
1−ベンジル体0.2g(0.69mmol)を液体アン
モニア中0.05gのナトリウムで還元し、目的とす
る7〜を0.12g(87%)得た。融点〜190℃(分解)
〈実施例5〉 (例示化合物8〜,9〜の合成)
1.00g(32mmol)の()を15mlのN−メチ
ルピロリドンに加え、室温で攪拌し、これに無水
メトキシカルボニルプロピオン酸2.93gとトリプ
ロピルアミン4.8mlとを順に加え、130℃の油浴上
で3時間加熱した。冷却後酢酸エチルで希釈し、
水で洗浄した(100ml×2)。酢酸エチル層を無水
硫酸マグネシウムで乾燥後、濃縮し、これにメタ
ノール30mlと濃塩酸20mlを加え、7時間加熱還流
した。冷却後エタノールを減圧濃縮して除き、残
渣を氷水100mlに注ぎ、中和してPH7としたのち、
酢酸エチルで抽出した(50ml×3)。酢酸エチル
層を無水硫酸マグネシウムで乾燥したのち濃縮
し、シリカゲルカラム(20g)で精製して8〜
0.16g(17%)を油状物として得た。
核磁気共鳴スペクトル(CDCl3)
δ(ppm):2.42(3H,s)2.60〜3.15(4H,m)
3.63(3H,s)5.02(2H,s)5.26(1H,s)
7.12〜7.50(5H,m)
元素分析値 C(%) H(%) N(%)
理論値 64.41 6.08 18.78
実験値 64.22 6.30 18.55
このN−ベンジル体を上記と同様にナトリウム
還元して例示化合物9〜を約80%の収率で得ること
ができた。融点120〜122℃
〈実施例6〉 (例示化合物11〜,12〜,13〜,
14〜の合成)
9.5g(30mmol)の()と65g(150mmol)
の無水4−(p−ニトロフエニル)酪酸及び57ml
(300mmol)のトリプロピルアミンを150mlの
DMFに溶解した。この混合物を攪拌下、130℃の
油浴上で4時間、続いて140℃の油浴上で2時間、
さらに160℃の油浴上で6時間加熱した。DMFを
減圧下に留去したのち酢酸エチルに溶解し、この
酢酸エチル溶液を2N NaOH水溶液で洗浄(2
回)した。酢酸エチル層を無水硫酸マグネシウム
上で乾燥したのち、濃縮し、シリカゲルカラムク
ロマトグラフイー(シリカゲル600g,溶出液ヘ
キサン:酢酸エチル=2:1〜1:1)にかけ、
7.6g(45%)の()(R1=−CH3,
【式】
R3=−(CH2)3C6H4−NO2)を得た。
核磁気共鳴スペクトル(CDCl3)
δ(ppm):2.40(3H,s)1.8〜3.3(12H,m)
5.80(2H,s)7.0〜7.4(9H,m)8.1(4H,
m)
7.6g(13mmol)の()をEtOH150mlと濃
塩酸50mlとの混合溶媒に溶解し、10時間加熱還流
した。水100mlを加えたのちエタノールを減圧濃
縮して除いた。アンモニア水で中和したのち酢酸
エチルで抽出し、酢酸エチル層を無水硫酸マグネ
シウム上で乾燥した。濃縮後、シリカゲルカラム
クロマトグラフイー(シリカゲル140g、溶出液
ヘキサン:酢酸エチル=1:1)にかけ()
(R1=−CH3,【式】R3=−
(CH2)3C6H4NO2)3.8g(76%)を得た。
核磁気共鳴スペクトル(CDCl3)
δ(ppm):2.03(2H,m)2.44(3H,s)2.58
〜2.85(4H,m)5.02(2H,s)5.20(1H,
s)7.04〜7.40(7H,m)8.04(2H,d,J
=8.0)
イソプロピルアルコール80mlに還元鉄18g
(0.32mol)、塩化アンモニウム1.3g(25mmol)
及び水8mlを加えて激しく攪拌しながら還流状態
になるまで加熱した。これに濃塩酸0.2mlを加え
て30分間加熱還流した。これに上記ニトロ体18.0
g(47.9mmol)を20分間かけて少しずつ加え、
さらに1時間加熱還流した。セライトでろ過し、
セライトをエタノールでよく洗浄した。ろ液を濃
縮したのち酢酸エチルに溶解し、これを水洗した
のち、無水硫酸マグネシウム上で乾燥した。濃縮
して粗生成物アニリン体(()のR3=−(CH2)
3C6H4NH2)15.8g(95%)を得た。
核磁気共鳴スペクトル(CDCl3)
δ(ppm):1.95(2H,m)2.38(3H,s)2.40
〜2.76(4H,m)3.36(2H,br)4.97(2H,
s)5.20(1H,s)6.53(2H,m)6.91(2H,
m)7.00〜7.38(5H,m)
このアニリン体15.8g(45.7mmol)を還流状
態の液体アンモニア200mlに加え攪拌した。これ
に金属ナトリウム2.6g(0.11mol)を少しずつ加
えた。これに塩化アンモニウムを少しずつ加えた
のち一夜放置してアンモニアを除去した。残渣を
2N HC1水溶液に溶解し、酢酸エチルで洗浄し
た。水層をアンモニア水で中和して、析出した沈
澱をろ取した。沈澱を水で、つづいてアセトニト
リルで洗浄ののち乾燥してほとんど純粋な117.9
g(68%)を得た。融点199〜203℃
核磁気共鳴スペクトル
(CDCl3+DMSO−d6)
δ(ppm):1.88(2H,br,quintet,J=〜7)
2.41(3H,s)2.3〜2.8(4H)5.42(1H,s)
6.56(2H,d,J=8.5)6.90(2H,d,J=
8.5)
質量分析スペクトル
255(M+,20%)136(100),119(90)
106(50)
赤外線吸収スペクトル(KBr)
3340,1605,1507,1380,1270cm-1
11 3.00g(11.7mmol)をアセトニトリル50ml
に加え、これにN,N−ジメチルアセトアミド25
mlを加えて攪拌下還流状態になるまで加熱した。
これに酸クロリド
7.19g(12.9mmol)のアセトニトリル溶液(20
ml)を20分間で滴下し、さらに20分間還流した。
さらに上記酸クロリド0.72g(0.13mmol)のア
セトニトリル溶液(10ml)を10分間で滴下したの
ち、30分間還流を続けた。冷却後、水500mlに注
ぎ酢酸エチルで抽出した。酢酸エチル層を無水硫
酸マグネシウムで乾燥後、濃縮し、シリカゲルカ
ラムクロマトグラフイー(シリカゲル300g、溶
出液クロロホルム:メタノール=60:1)に供
し、7.25g(80%)の12(固体)を得た。
元素分析値 C(%) H(%) N(%) S(%)
理論値 69.65 6.88 9.02 4.13
測定値 68.99 6.90 8.90 4.07
質量分析(FD)776(M+,b.p)
核磁気共鳴スペクトル(CDCl3)
δ(ppm):0.86(3H,brt,J=7)1.0〜2.2
(20H,m)2.38(3H,s)2.5〜2.8(4H,m)
4.68(1H,brt,J=6)5.05(2H,s)5.45
(1H,s)6.9〜7.4(13H,m)7.7〜7.9(4H,
m)8.17(1H,s)11.6(1H,br)
3.3g(4.3mmol)のベンジル体12〜をTHF60
mlに溶かし、10%Pd/C 0.66gを加えた。これ
を60気圧の水素雰囲気下、60℃で3時間攪拌し
た。冷却後、触媒をろ過して除きろ液を濃縮し
た。シリカゲルカラムクロマトグラフイー(シリ
カゲル90g、溶出液クロロホルム:メタノール=
1:0〜30:1)に供し、2.7g(92%)の13〜
を固体として得た。
質量分析(FD)687(M++2,50%)
686(M++1,100)
685(M+,30)
4.25g(6.20mmol)の13〜とTHF50mlとをジ
クロロメタン100mlに加え、室温で攪拌して溶解
した。これに795mg(5.95mmol)のN−クロロコ
ハク酸イミドを加え、15分間室温で攪拌した。水
で洗浄(150ml×2)ののち無水硫酸マグネシウ
ム上で乾燥した。濃縮後、シリカゲルカラムクロ
マトグラフイー(シリカゲル100g、溶出液クロ
ロホルム:メタノール=50:1〜31:1)に付し
14〜 4.04g(90%)を固体として得た。
質量分析(FD)722,721,720(9:7:9)
〈実施例7〉 (例示化合物15〜,16〜の合成)
11,1.79g(7.00mmol)とN,N−ジメチル
アミド15mlをアセトニトリル30mlに加え、還流状
態になるまで加熱攪拌した。これに酸クロリド
〔(t−C5H11)2C6H3OCH(n−C4H9)COCl〕
2.83g(7.70mmol)のアセトニトリル溶液(10
ml)を15分間かけて滴下し、さらに30分間還流を
続けた。冷却後、水300mlに注ぎ、酢酸エチルで
抽出した。酢酸エチル層を無水硫酸マグネシウム
上で乾燥したのち濃縮し、シリカゲルカラムクロ
マトグラフイー(シリカゲル100g、溶出液クロ
ロホルム:メタノール70:1)で分取し、15〜を
3.12g(76%)固体として得た。
元素分析値 C(%) H(%) N(%)
理論値 73.81 8.77 11.95
測定値 73.64 8.95 11.93
核磁気共鳴スペクトル(CDCl3)
δ(ppm):0.50〜1.00(7H,m)1.00〜2.16
(26H,m)2.44(3H,s)2.46〜2.80(4H,
m)4.66(1H,t,J=6.0)5.44(1H,s)
6.90〜7.34(6H,m)7.64(1H,d,J=9.0)
7.87(1H,br,s) DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to novel pyrazolo[1,5-b][1,
2,4] relates to a method for producing a triazole derivative. (Background of the Invention) A nitrogen atom at the bridgehead position, at least two in total, capable of interacting with 10 π electrons including the lone pair of this nitrogen atom and another nitrogen atom,
General formula with up to 6 nitrogen atoms ...; Indicates three double bonds that can be moved.・; Indicates nitrogen or carbon atom. The 5-5 fused polycyclic compound represented by is commonly called "azapentalene". Until now, this compound has been studied mainly from structural chemistry, interest as a organizing active substance, and interest as a magenta coupler in photochemistry (J. Elgureo,
R. Jacquier, S. Mignonac-Mondon, J.
Heterocyclic.Chem., 10 , 411 (1973), H. Koga,
M.Hirobe, T.Okamoto, Chem.Pharm.Bull.,
22, 482 (1974), J.Bailey, JCSPerkin I2047
(1977), Japanese Patent Publication No. 1977-27411, Japanese Patent Publication No. 129586, 1977
(see issue, etc.). The present inventors have conducted various studies on methods for synthesizing such azapentalene compounds, and as a result, they have succeeded in producing azapentalene compounds with novel skeletons by cyclization condensation of certain N-aminotriazolium salts and acid anhydrides. It has been found that the compound exhibits extremely excellent properties as a magenta coupler for color photography, and based on this knowledge, the present invention has been completed. (Structure of the invention) That is, the present invention comprises: 1. General formula (In the formula, R 1 represents a hydrogen atom, an alkyl group, a substituted alkyl group, an aryl group, or a substituted aryl group, R 2 represents an alkyl group, a substituted alkyl group, an aryl group, or a substituted aryl group, and X represents an acid group. ) and the general formula (R 3 CO) 2 O or (In the formula, R 3 represents a hydrogen atom, an alkyl group, a substituted alkyl group, an aryl group, or a substituted aryl group.) (In the formula, R 1 , R 2 and R 3 have the same meanings as above.) 7-acylated pyrazolo [1,5-
b] [1,2,4]triazole was obtained, and the 7-position acyl group of this compound was deacylated to give the general formula (In the formula, R 1 , R 2 and R 3 have the same meanings as above.) Pyrazolo[1,5-b][1,2,
4] Obtain a triazole derivative and reduce the 1-position of this compound to form the general formula (In the formula, R 1 and R 3 have the same meanings as above.)
A method for producing a pyrazolo[1,5-b][1,2,4]triazole derivative, characterized in that the compound is a compound represented by the following general formula: (In the formula, R 1 represents a hydrogen atom, an alkyl group, a substituted alkyl group, an aryl group, or a substituted aryl group, and R 2 represents an alkyl group, a substituted alkyl group, an aryl group, or a substituted aryl group.) The compound is N-aminated to form the general formula (In the formula, R 1 and R 2 have the same meanings as above.
X represents an acid radical. ) was obtained, and this N-aminotriazolium salt was subjected to cyclization condensation with an acid anhydride represented by the general formula () in the same manner as in the method of item 1) above. , 7 expressed by the general formula ()
-Acylated pyrazolo[1,5-b][1,2,4]
A triazole is obtained, the 7-position acyl group is deacylated to obtain a pyrazolo[1,5-b][1,2,4]triazole derivative represented by the general formula (), and this 1-position is reduced. , a method for producing a pyrazolo[1,5-b][1,2,4]triazole derivative, which comprises obtaining a compound represented by the general formula (). It provides: The above general formula (), (), (), (), ()
and R 1 and R 3 in the compound represented by ()
Alkyl groups include lower alkyl groups such as methyl, ethyl, propyl, and butyl groups to higher alkyl groups having up to 22 carbon atoms, such as pentyl group, hexyl group, heptyl group, octyl group, decyl group, undecyl group, and tridecyl group. group, octadecyl group, etc., and may be linear or branched. In particular, R 1 is preferably a methyl group. Aryl groups for R 1 and R 3 include phenyl and naphthyl groups, and substituted alkyl groups include benzyl and
Examples of the substituted aryl group include a phenethyl group, and examples of the substituted aryl group include a halogenophenyl group, a nitrophenyl group, a cyanophenyl group, and an alkoxyphenyl group. In addition, these R 1 and R 3 are groups inert to the reaction,
For example, it may have an alkoxyl group, a nitro group, a cyano group, a halogen atom, etc. as a substituent. Next, as the alkyl group of R 2 in the compounds represented by the above general formulas () and (), methyl group,
It includes lower alkyl groups such as ethyl, propyl, and butyl groups, and higher alkyl groups such as pentyl, hexyl, and dodecyl groups.Aryl groups include phenyl and naphthyl groups, and substituted alkyl groups include benzyl groups. , phenethyl group, p-methoxyphenylmethyl group, m-nitrophenylmethyl group, etc., and these include groups that are inert to the same reaction as R 1 and R 3 as substituents. good. In particular, when R 2 is an optionally substituted benzyl group, the substituent can be easily removed reductively in a later step, which is advantageous when producing the 1H-form. In the above general formula (), the acid group of X is an acid group,
For example, halogen anions such as chlorine, bromine, and iodine, NO 3 , SO 2- 4 , [Formula] [Formula] [Formula] [Formula], etc. are included. Note that the pyrazolo[1,5-b][1,2,4]triazole derivative obtained by the method of the present invention further has a substituent as described above on the R 1 , R 2 or R 3 group. The compound can be obtained directly according to the reaction scheme described below, but in this step, the basic skeleton of the present invention, pyrazolo-[1,5-
b] After forming a [1,2,4]triazole ring, a desired substituent may be derived through a subsequent reaction. If necessary, the 7-position is an acyl group, R 2
may be derived with a compound having a protecting group such as a benzyl group. For example, as shown in Example 6 below, the amino groups of compounds 11-- of the present invention can be derived into acid anilides 13-, etc. by a known method. The reaction process of the method of the present invention is as follows when X in the general formula () is an iodine ion. In addition, the general formula () obtained by the method of the present invention
A coupling-off group known in photographic couplers may be introduced into the 7-position of the compound represented by the formula to form a photographic coupler. This is shown in the step ()→() in the reaction process below. Reaction equation Hereinafter, embodiments of the method of the present invention will be described according to the above reaction scheme. In the present invention, the triazole compound () can be easily obtained by reacting an oxadiazole () with an organic primary amine (). The reaction temperature is usually 50
Start at a temperature of ~150°C and complete under conditions where the water produced by the dehydration reaction gently refluxes. The reaction time is usually in the range of 0.1 to 6 hours, but is not limited thereto. In addition, oxadiazole is Ber., Vol. 32, 797
(1899). Next, the synthesis of N-aminotriazolium salt () by amination of the triazole compound () is as follows:
This can be carried out using hydroxylamine-O-sulfonic acid, O-(2,4-dinitrophenyl)hydroxylamine, or O-diphenylphosphorylhydroxylamine as an aminating agent. Other aminating agents that can be used in the present invention include Y.
Tamuraet, al., Synthesis, 1977, 1-17 and the references therein. This amination reaction is usually carried out at a reaction temperature of 0°C to 100°C for 0.1 to 5 hours. The molar ratio of the triazole compound to the aminating agent is generally 1:1, but the cheaper one of the two may be used in excess. The cyclization condensation reaction between the N-aminotriazolium salt () and the acid anhydride () is carried out in the presence of a base. As the base, amines, sodium acetate, sodium propionate, etc. can be used. In this reaction, it is desirable to use at least 3 equivalents of the acid anhydride and at least 5 equivalents of the base based on the N-aminotriazolium salt. If the amounts of acid anhydride and base are less than this lower limit, the reaction yield will decrease. This is considered to be because when the acid anhydride content is less than the above-mentioned lower limit, a side reaction that does not give the target product from the reaction intermediate proceeds. The reaction temperature is generally 100
℃~180℃ can be used, but 120℃ or higher is preferable.
The reaction time varies depending on the type and amount of acid anhydride.
There is no particular limit, but it generally ranges from 0.5 to 20 hours. The reaction solvent may be any inert solvent; for example, dimethylformamide (DMF), dimethylacetamide, N-methylpyrrolidone, etc. are commonly used; however, when lower acid anhydrides are used as reaction components, An excess amount of this can also be used as a solvent. Specific examples of acid anhydrides include formic anhydride,
Acetic anhydride, propionic anhydride, lauric anhydride,
Examples include benzoic anhydride, methoxycarbonylpropionic anhydride, ethoxycarbonylpropionic anhydride, and 4-(p-nitrophenyl)butyric anhydride. Further, the acid anhydride of the above general formula () also includes mixed acid anhydrides, and a preferred example in this case is a mixed acid anhydride with trimethyl acetic acid. Compound () is obtained by deacylating 7-acylated pyrazolo[1,5-b][1,2,4]triazole (), which is the product of this cyclization condensation reaction. Deacylation can be achieved by heating under reflux in an aqueous solution containing a solvent boiling at room temperature to 200° C., such as ethanol, under acidic conditions using a mineral acid, according to a general method. After returning this to neutrality, the target product is isolated by extraction or the like, and purified if necessary. Note that the deacylation reaction may be performed simultaneously with the nitrosation at the 7-position. Next, by reduction of the compound (), the substituent R 2 bonded to the 1-position nitrogen atom is removed to obtain the 1H-pyrazolo[1,5-b][1,2,4]triazole compound (). . It is desirable to select a substituent R 2 that can be suitably removed by this reduction treatment. Such protective groups are described, for example, by Mcomie, Protective Groups in Organic
Chemistry (1973, published by Plenum) or T.
By W. Green Protective Groups in Organic
Synthesis (1981, published by Wiley-Interscience)
are often described. Among these , R2 preferable for use in the present invention is -CH2C6H5 , -CH( C6H5 ) 2 , -CH2C6H3-3,4- ( OCH3 ) 2 , -CH2C6H4- o - NO2 , -CH2C6H4 -p- OCH3 , -CH( C6H4 - p - OCH3 ) 2 , -CH2-2 - pyridyl -N-oxide and the like. Reaction conditions for removing these substituents R 2 include catalytic reduction or reduction with an alkali metal. For example,
Palladium black/hydrogen, palladium-carbon/hydrogen,
Examples include palladium-alumina/hydrogen, sodium/liquid ammonia, and lithium/liquid ammonia. Among them, sodium metal/liquid ammonium gives a high yield. Although the desired compound obtained in each step of the above reaction process may be subjected to the subsequent reaction without being isolated in any way, it is usually isolated and purified by appropriate isolation means. Examples of such methods include solvent extraction,
Recrystallization method, filtration method, column chromatography,
Examples include thin layer chromatography. Next, pyrazolo[1,5-b][1,2,4] represented by the above general formulas (), () and ()
Specific examples of triazole derivatives are illustrated below, but it goes without saying that the present invention is not limited thereto. However, among the exemplified compounds below, 4, 14, 16, 17-
20 represents a compound obtained by further introducing a coupling-off group of a photographic coupler into the 7-position of the 1H-pyrazolo[1,5-b][1,2,4]triazole derivative, which is the object compound of the present invention. , is shown as a reference compound. (Effects of the Invention) According to the present invention, pyrazolo[1,5-b][1, 2,4] triazole derivatives can be produced. Furthermore, the compound of the present invention has the possibility of being used as a physiologically active substance, and can also be used as an intermediate for pharmaceutical production. (Examples) Next, the present invention will be described in more detail based on Examples. Example 1 (Synthesis of Exemplary Compounds 1-, 2-, 3-) (A) Synthesis of 1-amino-4-benzyl-3,5-dimethyltriazolium iodide () In the following examples, unless otherwise specified, () represents this 1-amino-4-benzyl-
3,5-dimethyltriazolium iodide was used. () 19 g (0.19 mol) of 2,5-dimethyl-1,3,4-oxadiazole () obtained by thermal decomposition of tetraacetylhydrazine and 31 g (0.29 mol) of benzylamine were reacted at 110°C for 4 hours, 4-benzyl-3,5-dimethyl-1,2,
26 g of 4-triazole () was obtained. Yield 73%,
Melting point 125-127℃. Hydroxylamine-O-sulfonic acid 66g
(0.58mol) and potassium hydroxide 40g (85%,
Hydroxylamine prepared from
An aqueous solution of potassium O-sulfonate and 75 g (0.4 mol) of the above triazole () were reacted at 80 to 90°C for 6 hours, and after returning to room temperature, the pH was adjusted to 8 to 9 with a 50% aqueous potassium carbonate solution. The generated potassium sulfate was filtered off, and the filtrate was extracted three times with chloroform. 44 g (59%) of the starting material triazole was recovered from this chloroform extract. The aqueous layer was brought to pH 3 with a 57% aqueous hydriodic acid solution under ice cooling, and crystals were precipitated. By filtering this crystal and recrystallizing it from ethanol at -20℃, 39 g of
(31%) was obtained as pale yellow crystals. () O-(2,4-dinitrophenyl)hydroxylamine as an aminating agent (J.Org.
Chem.38 1239 (1973)) was used to synthesize () as follows. Add 35 g (0.19 mol) of 4-benzyl-1,2,4-triazole () to 300 ml of dichloroethane, stir vigorously while heating to 70°C, and add O.
25 g (0.13 mol) of -(2,4-dinitrophenyl)hydroxylamine were added portionwise (over about 35 minutes) and stirred for a further 2 hours at this temperature.
After dichloroethane was distilled off under reduced pressure, the residue was dissolved in 100 ml of water, and the pH was adjusted to 3 with a 57% aqueous solution of hydroiodic acid. 2,4-dinitrophenol precipitated, but was removed by extraction with ethyl acetate (three times).
The aqueous layer was concentrated and the residue was recrystallized from ethanol to obtain () in 70% yield. In addition, as an aminating agent, O-diphenylphosphinylhydroxylamine (Synthesis, 592
(1982), Tetrahedron Lett., 23 , 3835 (1982))
When using , do almost the same thing, but in this case,
After treatment with hydroiodic acid, diphenylphosphinic acid is recovered by filtration without extraction (more than 90%)
We were able to. (B) Synthesis of 7-acetyl-1-benzyl-2,6-dimethylpyrazolo[1,5-b][1,2,4]triazole (1) N-aminotriazolium iodide () 8g
(0.025mol) in DMF (dimethylformamide) 50
ml, added 40 ml of acetic anhydride, and heated to 120°C. Next, add 12.5 g of sodium acetate and add 12.5 g of sodium acetate.
Stirred at ~130°C for 4 hours. After removing DMF, acetic anhydride, etc. under reduced pressure, it was made basic with a saturated aqueous sodium carbonate solution, extracted with chloroform, the extract was dried over anhydrous magnesium sulfate, and the solvent was distilled off to obtain a brown oil. Ta. This was purified using a silica gel column in a solvent system of n-hexane-ethyl acetate, and 7-acetyl-1-benzyl-
2,6-dimethylpyrazolo[1,5-b][1,
3.2 g (47%) of 2,4] triazole (1) was obtained.
Melting point 105-107℃ Nuclear magnetic resonance spectrum ( CDCl3 ) δ (ppm): 2.36 (3H, s) 2.43 (3H, s) 2.60
(3H, s) 5.80 (2H, s) 7.0~7.2 (2H) 7.2
~7.36(3H) (C) Synthesis of 1-benzyl-2,6-dimethylpyrazolo[1,5-b][1,2,4]triazole (2) ~ Dissolve 1 to 2 g (7.5 mmol) in 20 ml of ethanol, add 20 ml of concentrated hydrochloric acid, and heat to reflux.
After about 6 hours, the ethanol was removed under reduced pressure, basified with a saturated aqueous solution of sodium bicarbonate, and extracted with ethyl acetate to yield nearly pure deacetylated 1-benzyl-2,6-dimethylpyrazolo[1,5- b]
~1.6 g (95%) of [1,2,4]triazole (2) was obtained. Melting point 87-88℃ Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 2.32 (3H, s) 2.44 (3H, s) 5.02
(2H, s) 5.22 (1H, s) 7.10-7.40 (5H) (D) 1H-2,6-dimethylpyrazolo[1,5-
b] Synthesis of [1,2,4]triazole (3) 1-Benzyl-2,6-dimethylpyrazolo[1,5-b][1,2,4]triazole (2) to 1.6
g (7.1 mmol) with about 0.8 g of metallic sodium in liquid ammonia to obtain the desired 1H-2,6
-dimethylpyrazolo[1,5-b][1,2,4]
0.67 g (70%) of triazole (3) was obtained as colorless crystals. Melting point 274-275℃ (decomposition) Mass spectrometry 136 (M + , 100%) Elemental analysis values C (%) H (%) N (%) Theoretical value 52.93 5.92 41.15 Measured value 52.85 6.02 41.01 Nuclear magnetic resonance spectrum (CDCl 3 :pyridine-d 5
= 1:1) δ (ppm): 2.35 (3H, s) 2.43 (3H, s) 5.50
(1H, s) <Example 2> (Synthesis of exemplified compounds 5~) 5 g (16 mmol) of N-aminotriazolium iodide () shown in Example 1, 30 g (79 mmol) of 5 equivalents of lauric anhydride, and 11 g (77 mmol) of tripropylamine were mixed in 100 ml of DMF at 140 to 150°C for about 10 hours. Heated. DMF was removed using an evaporator, ethyl acetate was added, precipitated unreacted lauric anhydride was removed by filtration, and the filtrate was transferred to a separating funnel.
Add 2N aqueous sodium hydroxide solution and shake thoroughly.
The liquid was separated. The aqueous layer was further extracted twice with ethyl acetate, and the ethyl acetate layer was washed with saturated brine.
It was dried over magnesium sulfate, and 30 ml of concentrated hydrochloric acid and 50 ml of ethanol were added to the resulting residue, and the mixture was reduced by heating for about 4 hours, the ethanol was removed, and the mixture was extracted with ethyl acetate. The product was subjected to usual post-treatment and purified using a silica gel column to obtain 0.8 g (14%) of 1-benzyl compound. Nuclear magnetic resonance spectrum ( CDCl3 ) δ (ppm): 0.88 (3H, brt, J = ~7) 1.30
(20H, brs) 2.40 (3H, s) 2.60 (2H, t,
J=7.5) 5.03 (2H, s) 5.25 (1H, s) 7.10
~7.45 (5H) This 1-benzyl compound was reduced with sodium in liquid ammonia to obtain Exemplified Compound 5~, which is sparingly soluble in organic solvents other than alcohol, in a yield of about 90%. Melting point 154
~155°C <Example 3> (Synthesis of Exemplary Compound 6) 7.2 g (55 mmol) of n-heptanoic acid was dissolved in 15 ml of dimethylformamide (DMF), 7.9 g (55 mmol) of tri-n-propylamine was added thereto, and then 6.1 g (51 mmol) of trimethylacetyl chloride was dissolved in 10 ml of DMF. was added dropwise.
After stirring at room temperature for 10 minutes, 5 g (15.8 mmol) of N-aminotriazolium iodide () and 11.3 g (79 mmol) of tri-n propylamine were gradually added to
℃ and stirred at that temperature for about 5 hours.
After DMF and amine were distilled off under reduced pressure, 100 ml of 2N aqueous sodium hydroxide solution was added, and the mixture was extracted three times with ethyl acetate. The extract was washed with water and saturated brine, and dried over magnesium sulfate. After filtration, it was concentrated under reduced pressure, and the residue was purified by silica gel chromatography.
2.9 g (45%) of (R 1 =-CH 3 , [Formula] R 3 =-C 6 H 13 ) was obtained. When this was deacylated and debenzylated by the method shown in (C) and (D) of Example 1, 1.0g (68%) of 6-
I was able to get it. Melting point 105-110℃ Nuclear magnetic resonance spectrum (DMSO-d 6 ) δ (ppm): 0.85 (3H, brt, J = ~7) 1.32
(8H, brs) 2.45 (3H, s) 2.58 (2H, t, J
=7.5) 5.60 (1H, s) <Example 4> (Synthesis of Exemplary Compounds 7~) () 1.0g (3.16mmol) in 8ml of anhydrous DMF
Dissolve 3.6 g of benzoic anhydride in the solution.
(15.8 mmol) and 2.3 g of tri-n-propylamine
(15.8 mmol) was added, and the mixture was heated and stirred at 130°C for 24 hours. After DMF and tri-n-propylamine were distilled off under reduced pressure, 30 ml of ethanol and 10 ml of concentrated hydrochloric acid were added, and the mixture was heated under reflux for 5 days. After removing ethanol and concentrated hydrochloric acid under reduced pressure,
After extraction with ethyl acetate, drying, concentration, and purification by silica gel chromatography, the 1-benzyl compound was obtained.
0.2g (22%) was obtained. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 2.35 (3H, s) 4.95 (2H, s) 5.65
(1H, s) 7.05-7.50 (8H) 7.80 (2H, dd,
J=9.0, 1.5) 0.2 g (0.69 mmol) of the 1-benzyl compound was reduced with 0.05 g of sodium in liquid ammonia to obtain 0.12 g (87%) of the desired 7-. Melting point ~190°C (decomposition) <Example 5> (Synthesis of exemplified compounds 8~, 9~) Add 1.00 g (32 mmol) of () to 15 ml of N-methylpyrrolidone and stir at room temperature. To this, 2.93 g of methoxycarbonylpropionic anhydride and 4.8 ml of tripropylamine were added in order, and the mixture was heated on an oil bath at 130°C. Heated for 3 hours. After cooling, dilute with ethyl acetate,
Washed with water (100ml x 2). The ethyl acetate layer was dried over anhydrous magnesium sulfate, concentrated, and 30 ml of methanol and 20 ml of concentrated hydrochloric acid were added thereto, followed by heating under reflux for 7 hours. After cooling, ethanol was removed by concentration under reduced pressure, and the residue was poured into 100 ml of ice water and neutralized to pH 7.
Extracted with ethyl acetate (50ml x 3). The ethyl acetate layer was dried over anhydrous magnesium sulfate, concentrated, and purified using a silica gel column (20 g).
Obtained 0.16 g (17%) as an oil. Nuclear magnetic resonance spectrum ( CDCl3 ) δ (ppm): 2.42 (3H, s) 2.60-3.15 (4H, m)
3.63 (3H, s) 5.02 (2H, s) 5.26 (1H, s)
7.12-7.50 (5H, m) Elemental analysis value C (%) H (%) N (%) Theoretical value 64.41 6.08 18.78 Experimental value 64.22 6.30 18.55 This N-benzyl compound was reduced with sodium in the same manner as above to obtain Exemplified Compound 9 ~ could be obtained with a yield of about 80%. Melting point 120-122°C <Example 6> (Exemplary compounds 11-, 12-, 13-,
Synthesis of 14~) 9.5g (30mmol) () and 65g (150mmol)
of 4-(p-nitrophenyl)butyric anhydride and 57 ml
(300mmol) of tripropylamine in 150ml
Dissolved in DMF. The mixture was heated under stirring on a 130°C oil bath for 4 hours, followed by a 140°C oil bath for 2 hours.
The mixture was further heated on an oil bath at 160°C for 6 hours. After DMF was distilled off under reduced pressure, it was dissolved in ethyl acetate, and this ethyl acetate solution was washed with 2N NaOH aqueous solution (2
times). The ethyl acetate layer was dried over anhydrous magnesium sulfate, concentrated, and subjected to silica gel column chromatography (600 g of silica gel, eluent: hexane: ethyl acetate = 2:1 to 1:1).
7.6 g (45%) of () (R 1 = −CH 3 ,
[Formula] R 3 =-(CH 2 ) 3 C 6 H 4 -NO 2 ) was obtained. Nuclear magnetic resonance spectrum ( CDCl3 ) δ (ppm): 2.40 (3H, s) 1.8-3.3 (12H, m)
5.80 (2H, s) 7.0~7.4 (9H, m) 8.1 (4H,
m) 7.6 g (13 mmol) of () was dissolved in a mixed solvent of 150 ml of EtOH and 50 ml of concentrated hydrochloric acid, and heated under reflux for 10 hours. After adding 100 ml of water, ethanol was removed by concentration under reduced pressure. After neutralization with aqueous ammonia, extraction was performed with ethyl acetate, and the ethyl acetate layer was dried over anhydrous magnesium sulfate. After concentration, it was subjected to silica gel column chromatography (140 g of silica gel, eluent: hexane: ethyl acetate = 1:1).
(R 1 =-CH 3 , [Formula] R 3 =- (CH 2 ) 3 C 6 H 4 NO 2 ) 3.8 g (76%) was obtained. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 2.03 (2H, m) 2.44 (3H, s) 2.58
~2.85 (4H, m) 5.02 (2H, s) 5.20 (1H,
s) 7.04~7.40 (7H, m) 8.04 (2H, d, J
=8.0) 18g reduced iron in 80ml isopropyl alcohol
(0.32mol), ammonium chloride 1.3g (25mmol)
and 8 ml of water were added, and the mixture was heated with vigorous stirring until it reached reflux. To this was added 0.2 ml of concentrated hydrochloric acid, and the mixture was heated under reflux for 30 minutes. This includes the above nitro body 18.0
g (47.9 mmol) was added little by little over 20 minutes,
The mixture was further heated under reflux for 1 hour. Filter through celite,
Celite was thoroughly washed with ethanol. The filtrate was concentrated, dissolved in ethyl acetate, washed with water, and dried over anhydrous magnesium sulfate. Concentrate to obtain the crude aniline product (R 3 = -(CH 2 )
15.8 g (95%) of 3 C 6 H 4 NH 2 was obtained. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 1.95 (2H, m) 2.38 (3H, s) 2.40
~2.76 (4H, m) 3.36 (2H, br) 4.97 (2H,
s) 5.20 (1H, s) 6.53 (2H, m) 6.91 (2H,
m) 7.00 to 7.38 (5H, m) 15.8 g (45.7 mmol) of this aniline compound was added to 200 ml of liquid ammonia under reflux and stirred. 2.6 g (0.11 mol) of metallic sodium was added little by little to this. Ammonium chloride was added little by little to this, and the mixture was left to stand overnight to remove ammonia. residue
It was dissolved in 2N HC1 aqueous solution and washed with ethyl acetate. The aqueous layer was neutralized with aqueous ammonia, and the precipitate was collected by filtration. The precipitate was washed with water and then with acetonitrile and dried to produce almost pure 117.9.
g (68%). Melting point 199-203℃ Nuclear magnetic resonance spectrum (CDCl 3 + DMSO-d 6 ) δ (ppm): 1.88 (2H, br, quintet, J = ~7)
2.41 (3H, s) 2.3~2.8 (4H) 5.42 (1H, s)
6.56 (2H, d, J = 8.5) 6.90 (2H, d, J =
8.5) Mass spectrometry spectrum 255 (M + , 20%) 136 (100), 119 (90) 106 (50) Infrared absorption spectrum (KBr) 3340, 1605, 1507, 1380, 1270 cm -1 11 3.00 g (11.7 mmol) acetonitrile 50ml
In addition to this, N,N-dimethylacetamide 25
ml and heated under stirring until it reached reflux.
In this, acid chloride 7.19 g (12.9 mmol) of acetonitrile solution (20
ml) was added dropwise over 20 minutes, and the mixture was further refluxed for 20 minutes.
Furthermore, an acetonitrile solution (10 ml) containing 0.72 g (0.13 mmol) of the above acid chloride was added dropwise over 10 minutes, and reflux was continued for 30 minutes. After cooling, it was poured into 500 ml of water and extracted with ethyl acetate. The ethyl acetate layer was dried over anhydrous magnesium sulfate, concentrated, and subjected to silica gel column chromatography (300 g of silica gel, eluent chloroform:methanol = 60:1) to obtain 7.25 g (80%) of 12 (solid). . Elemental analysis values C(%) H(%) N(%) S(%) Theoretical value 69.65 6.88 9.02 4.13 Measured value 68.99 6.90 8.90 4.07 Mass spectrometry (FD) 776 (M + , bp) Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 0.86 (3H, brt, J=7) 1.0 to 2.2
(20H, m) 2.38 (3H, s) 2.5~2.8 (4H, m)
4.68 (1H, brt, J=6) 5.05 (2H, s) 5.45
(1H, s) 6.9~7.4 (13H, m) 7.7~7.9 (4H,
m) 8.17 (1H, s) 11.6 (1H, br) 3.3 g (4.3 mmol) of benzylic compound 12 ~ in THF60
ml and added 0.66 g of 10% Pd/C. This was stirred at 60°C for 3 hours under a hydrogen atmosphere of 60 atmospheres. After cooling, the catalyst was removed by filtration and the filtrate was concentrated. Silica gel column chromatography (silica gel 90g, eluent chloroform: methanol =
1:0~30:1), 2.7g (92%) of 13~
was obtained as a solid. Mass spectrometry (FD) 687 (M + +2, 50%) 686 (M + +1,100) 685 (M + , 30) Add 4.25 g (6.20 mmol) of 13~ and 50 ml of THF to 100 ml of dichloromethane and stir at room temperature. and dissolved. To this was added 795 mg (5.95 mmol) of N-chlorosuccinimide, and the mixture was stirred at room temperature for 15 minutes. After washing with water (150 ml x 2), it was dried over anhydrous magnesium sulfate. After concentration, the residue was subjected to silica gel column chromatography (100 g of silica gel, eluent: chloroform:methanol = 50:1 to 31:1) to obtain 14 to 4.04 g (90%) as a solid. Mass spectrometry (FD) 722, 721, 720 (9:7:9) <Example 7> (Synthesis of exemplified compounds 15~, 16~) 1.79 g (7.00 mmol) of N,N-dimethylamide and 15 ml of N,N-dimethylamide were added to 30 ml of acetonitrile, and the mixture was heated and stirred until it reached a reflux state. Add acid chloride [(t-C 5 H 11 ) 2 C 6 H 3 OCH (n-C 4 H 9 )COCl] to this.
2.83 g (7.70 mmol) of acetonitrile solution (10
ml) was added dropwise over 15 minutes, and reflux was continued for an additional 30 minutes. After cooling, it was poured into 300 ml of water and extracted with ethyl acetate. The ethyl acetate layer was dried over anhydrous magnesium sulfate, concentrated, and fractionated using silica gel column chromatography (100 g of silica gel, eluent chloroform:methanol 70:1).
Obtained 3.12 g (76%) as a solid. Elemental analysis value C (%) H (%) N (%) Theoretical value 73.81 8.77 11.95 Measured value 73.64 8.95 11.93 Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 0.50-1.00 (7H, m) 1.00-2.16
(26H, m) 2.44 (3H, s) 2.46~2.80 (4H,
m) 4.66 (1H, t, J=6.0) 5.44 (1H, s)
6.90~7.34 (6H, m) 7.64 (1H, d, J=9.0)
7.87 (1H, br, s)
Claims (1)
ルキル基、アリール基又は置換アリール基を示
し、R2はアルキル基、置換アルキル基、アリー
ル基又は置換アリール基を示し、Xは酸根を示
す。) で表わされるN−アミノトリアゾリウム塩と一般
式 (R3CO)2O又は【式】 (式中R3は水素原子、アルキル基、アリール
基又は置換アリール基を示す。) で表わされる酸無水物とを環化縮合させて、一般
式 (式中、R1,R2及びR3は前記と同じ意味をも
つ。) で表わされる7−アシル化ピラゾロ[1,5−
b][1,2,4]トリアゾールを得、この化合
物の7位のアシル基を脱アシル化して一般式 (式中、R1,R2及びR3は前記と同じ意味をも
つ。) で表わされるピラゾロ[1,5−b][1,2,
4]トリアゾール誘導体を得、この化合物の一位
を還元して、一般式 (式中、R1及びR3は前記と同じ意味をもつ。) で表わされる化合物とすることを特徴とするピラ
ゾロ[1,5−b][1,2,4]トリアゾール
誘導体の製造方法。 2 一般式 (式中、R1は水素原子、アルキル基、置換ア
ルキル基、アリール基又は置換アリール基を示
し、R2はアルキル基、置換アルキル基、アリー
ル基又は置換アリール基を示す。) で表わされるトリアゾール化合物をN−アミノ化
して前記一般式 (式中、R1及びR2は前記と同じ意味をもつ。
Xは酸根を示す。) で表わされるN−アミノトリアゾリウム塩を得、
このN−アミノトリアゾリウム塩と一般式 (R3CO)2O又は【式】 (式中R3は水素原子、アルキル基、アリール
基又は置換アリール基を示す。) で表わされる酸無水物とを環化縮合させて、一般
式 (式中、R1,R2及びR3は前記と同じ意味をも
つ。) で表わされる7−アシル化ピラゾロ[1,5−
b][1,2,4]トリアゾールを得、この化合
物の7位のアシル基を脱アシル化して一般式 (式中、R1,R2及びR3は前記と同じ意味をも
つ。) で表わされるピラゾロ[1,5−b][1,2,
4]トリアゾール誘導体を得、この化合物の1位
を還元して、一般式 (式中、R1及びR2は前記と同じ意味をもつ。) で表わされる化合物を得ることを特徴とするピラ
ゾロ[1,5−b][1,2,4]トリアゾール
誘導体の製造方法。[Claims] 1. General formula (In the formula, R 1 represents a hydrogen atom, an alkyl group, a substituted alkyl group, an aryl group, or a substituted aryl group, R 2 represents an alkyl group, a substituted alkyl group, an aryl group, or a substituted aryl group, and X represents an acid group. ) and an N-aminotriazolium salt represented by the general formula (R 3 CO) 2 O or [formula] (wherein R 3 represents a hydrogen atom, an alkyl group, an aryl group, or a substituted aryl group). The general formula (In the formula, R 1 , R 2 and R 3 have the same meanings as above.) 7-acylated pyrazolo [1,5-
b] [1,2,4]triazole was obtained, and the 7-position acyl group of this compound was deacylated to give the general formula (In the formula, R 1 , R 2 and R 3 have the same meanings as above.) Pyrazolo[1,5-b][1,2,
4] Obtain a triazole derivative and reduce the 1-position of this compound to form the general formula (In the formula, R 1 and R 3 have the same meanings as above.) A method for producing a pyrazolo[1,5-b][1,2,4]triazole derivative, characterized in that it is a compound represented by the following formula. 2 General formula (In the formula, R 1 represents a hydrogen atom, an alkyl group, a substituted alkyl group, an aryl group, or a substituted aryl group, and R 2 represents an alkyl group, a substituted alkyl group, an aryl group, or a substituted aryl group.) The compound is N-aminated to form the general formula (In the formula, R 1 and R 2 have the same meanings as above.
X represents an acid radical. ) to obtain an N-aminotriazolium salt represented by
This N-aminotriazolium salt and an acid anhydride represented by the general formula (R 3 CO) 2 O or [formula] (wherein R 3 represents a hydrogen atom, an alkyl group, an aryl group, or a substituted aryl group) By cyclization condensation, the general formula (In the formula, R 1 , R 2 and R 3 have the same meanings as above.) 7-acylated pyrazolo [1,5-
b] [1,2,4]triazole was obtained, and the 7-position acyl group of this compound was deacylated to give the general formula (In the formula, R 1 , R 2 and R 3 have the same meanings as above.) Pyrazolo[1,5-b][1,2,
4] Obtain a triazole derivative and reduce the 1-position of this compound to form the general formula (In the formula, R 1 and R 2 have the same meanings as above.) A method for producing a pyrazolo[1,5-b][1,2,4]triazole derivative, which is characterized by obtaining a compound represented by the following formula.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4560184A JPS60190779A (en) | 1984-03-12 | 1984-03-12 | Preparation of pyrazolo(1,5-b)(1,2,4)triazole derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4560184A JPS60190779A (en) | 1984-03-12 | 1984-03-12 | Preparation of pyrazolo(1,5-b)(1,2,4)triazole derivative |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP19490292A Division JPH0714940B2 (en) | 1992-06-29 | 1992-06-29 | Process for producing pyrazolo [1,5-b [1,2,4 triazole-based photographic coupler |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60190779A JPS60190779A (en) | 1985-09-28 |
JPH0479349B2 true JPH0479349B2 (en) | 1992-12-15 |
Family
ID=12723869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4560184A Granted JPS60190779A (en) | 1984-03-12 | 1984-03-12 | Preparation of pyrazolo(1,5-b)(1,2,4)triazole derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60190779A (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0715568B2 (en) | 1986-01-20 | 1995-02-22 | コニカ株式会社 | Silver halide color photographic light-sensitive material |
JPH068952B2 (en) * | 1986-08-07 | 1994-02-02 | 富士写真フイルム株式会社 | Color image forming method |
US4977269A (en) * | 1989-02-22 | 1990-12-11 | Eastman Kodak Company | Diacylation of pyrazolotriazoles |
AU2482192A (en) * | 1991-09-03 | 1993-04-05 | Yamanouchi Pharmaceutical Co., Ltd. | Pyrazolotriazole derivative |
FR2746307B1 (en) | 1996-03-22 | 1998-04-30 | Oreal | KERATINIC FIBER DYEING COMPOSITIONS CONTAINING PYRROLO-AZOLES; USE AS COUPLERS; DYEING PROCESS |
FR2746391B1 (en) | 1996-03-22 | 1998-04-17 | Oreal | COSMETIC COMPOSITIONS BASED ON PYRAZOLIN-4,5-DIONES, NEW PYRAZOLIN-4,5 DIONES, METHODS OF PREPARATION AND USES |
FR2746308B1 (en) * | 1996-03-22 | 1998-04-30 | Oreal | KERATINIC FIBER DYEING COMPOSITIONS CONTAINING IMIDAZOLO-AZOLES; THEIR USE IN DYEING AS COUPLERS; DYEING PROCESS |
FR2746310B1 (en) | 1996-03-22 | 1998-06-12 | Oreal | KERATINIC FIBER DYEING COMPOSITIONS CONTAINING PYRAZOLIN-3,5-DIONE; THEIR USE FOR DYEING AS COUPLERS, DYEING METHOD |
FR2746306B1 (en) | 1996-03-22 | 1998-04-30 | Oreal | KERATINIC FIBER DYEING COMPOSITIONS CONTAINING PYRAZOLO-AZOLES; THEIR USE FOR DYEING AS COUPLERS, DYEING METHOD |
FR2746309B1 (en) | 1996-03-22 | 1998-04-17 | Oreal | COMPOSITION FOR DYEING KERATIN FIBERS CONTAINING PYRAZOLOPYRIMIDINEOXO; THEIR USE FOR DYEING AS COUPLER, DYEING PROCESSES |
FR2772379B1 (en) | 1997-12-16 | 2000-02-11 | Oreal | DYE COMPOSITIONS OF KERATINIC FIBERS CONTAINING PYRAZOLO-AZOLES; THEIR USE FOR DYING AS AN OXIDIZING BASE, DYING PROCESS; NEW PYRAZOLO-AZOLES |
WO2000078274A2 (en) | 1999-06-22 | 2000-12-28 | Lion Corporation | Hairdye composition comprising indoline and/or an indoline compound and laccase |
FR2805737B1 (en) | 2000-03-06 | 2003-01-03 | Oreal | KERATINIC FIBER OXIDATION DYE COMPOSITION AND DYEING METHOD USING THE SAME |
FR2806299B1 (en) | 2000-03-14 | 2002-12-20 | Oreal | COMPOSITIONS FOR DYEING KERATINIC FIBERS CONTAINING PYRROLIDINYL GROUPED PARAPHENYLENEDIAMINE DERIVATIVES |
-
1984
- 1984-03-12 JP JP4560184A patent/JPS60190779A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60190779A (en) | 1985-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6061158B2 (en) | Synthesis intermediate of 6- (7-((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide, or a pharmaceutically acceptable salt thereof, and its use | |
JPH0456835B2 (en) | ||
JPH0479349B2 (en) | ||
US9458115B2 (en) | Synthesis of substituted pyrazines | |
JPH0479350B2 (en) | ||
US5410067A (en) | Process for the preparation of 5,6-dihydroxyindole and intermediate compounds | |
CA2289492C (en) | Synthesis of acridine derivative multidrug-resistant inhibitors | |
NO179517B (en) | Process for the preparation of 8-chloroquinolone derivatives | |
JP2001521498A (en) | Method for producing O- (3-amino-2-hydroxy-propyl) -hydroxymic acid halide | |
SU577990A3 (en) | Method of preparing n-(1-allylpyrrolidinyl-2-methyl)-2-methoxy-4,5-azimidobenzamide | |
JPH0730033B2 (en) | Process for producing substituted anthra [1,9-cd] pyrazol-6 (2H) -one | |
JP3711625B2 (en) | Method for producing 1H-pyrazolo [3,2-c] -1,2,4-triazole compound | |
JP2000281676A (en) | New production method of ampa antagonistic compound | |
JPH072742A (en) | New production method of 4-amino-3-methyl-n-ethyl-n-(beta-hydroxyethyl)aniline sulfuric acid salt | |
JPH04270272A (en) | Production of aminoalkylmorpholine derivative | |
JP2937387B2 (en) | Process for producing 5-substituted 2-amino-3-cyanopyrazines | |
JPS6317850A (en) | Production of 3-phenoxycatechols | |
KR810000293B1 (en) | Process for preparing substituted amino quinazoline derivatives | |
CN117677617A (en) | Preparation method of hepatitis B virus nucleocapsid inhibitor | |
JP3961049B2 (en) | 3-Amino-4- (1-hydroxyalkyl) pyrazoline compound, method for producing the same and method for producing the same | |
JPH0616642A (en) | Production of quinolinecarboxylic acid derivative | |
JPH0240672B2 (en) | 55FUENIRUAMINOO11FUENIRUU1HHPIRAZORO * 3 * 44B * PIRAJINJUDOTAI | |
JPH05202046A (en) | Pyrimidopteridine derivative and its production | |
JPS6051468B2 (en) | Method for producing 4-hydroxy-6-methylnicotinic acid | |
JPH06107634A (en) | Production of n-substituted phthalimide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |